(Q113888139)
Statements
Development and Validation of "Ready-to-Use" Inhalable Forms of Hydroxychloroquine for Treatment of COVID-19 (English)
0 references
15 July 2020
0 references
15 August 2020
0 references
40
0 references
18 year
0 references